Erin Van Schaik

Title: Erin Van Schaik: Innovator in Biofilm Inhibition

Introduction

Erin Van Schaik is a prominent inventor based in Calgary, Canada. She has made significant contributions to the field of biofilm inhibition, holding 2 patents that focus on innovative solutions to prevent biofilm formation on various surfaces. Her work is particularly relevant in biomedical and biotechnological applications.

Latest Patents

One of her latest patents is a non-toxic biofilm inhibitor. This invention relates to a composition, device, and method for preventing or inhibiting biofilm formation on both biotic and abiotic surfaces. The composition comprises a peptide based on the C-terminal receptor binding domain of type IV pilin, which binds to abiotic surfaces such as steel and plastic with high affinity. This innovative composition serves as a non-toxic inhibitor for biofilm formation, addressing a significant issue that leads to numerous diseases and substantial economic losses. The method is designed to be a safe and environmentally friendly means of modifying surfaces of various biomedical, nanotechnological, and biotechnological devices or articles.

Career Highlights

Erin Van Schaik is affiliated with the University of Colorado, where she continues her research and development in the field of biofilm inhibition. Her work has garnered attention for its potential applications in improving health outcomes and reducing economic impacts associated with biofilm-related issues.

Collaborations

She collaborates with notable colleagues, including Robert S. Hodges and Randall Thomas Irvin, who contribute to her research endeavors and help advance her innovative projects.

Conclusion

Erin Van Schaik is a trailblazer in the field of biofilm inhibition, with her patents reflecting her commitment to developing safe and effective solutions. Her contributions are poised to make a significant impact in various industries, enhancing both health and economic outcomes.